Clinical Trial

A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Name: A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis — clinical trial record (NCT07285304)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.

Trial Details

NCT Number	NCT07285304
Lead Sponsor	Taisho Pharmaceutical Co., Ltd.
Conditions	Hyperphosphatemia Patients on Hemodialysis
Enrollment	300 participants
Start Date	2025-12-01
Primary Completion	2027-07-31 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-16